INS and Alzheimer disease: While some of them target cognitive improvement of patients with AD using commercially available antidiabetic drugs/insulin sensitizers, others explore the beneficial effects of glucose metabolism‐related natural peptides or synthetic mimics/analogs of these natural peptides on neurodegeneration (Moreira et al., 2013).